Skip to main content
. 2024 Jul 3;12(7):e9153. doi: 10.1002/ccr3.9153

FIGURE 3.

FIGURE 3

Clinical course of the present case of a 59‐year‐old male patient with pembrolizumab‐induced myositis and cholangitis. ALT, alanine aminotransferase; AZA, azathioprine; CDDP, cisplatin; CK, creatine kinase; MMF, mycophenolate mofetil; PEM, pemetrexed; PSL, prednisolone; UDCA, ursodeoxycholic acid; γ‐GTP, gamma glutamyl transpeptidase.